Skip to main content
DFNS
NASDAQ Life Sciences

BiomX Inc. Acquires AI Defense Unit Zorronet, Issuing 19.87% Stake and $1.25M Note to T3 Defense Affiliate

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.498
Mkt Cap
$14.529M
52W Low
$0.421
52W High
$26.21
Market data snapshot near publication time

Summary

BiomX Inc. completed the acquisition of Zorronet, an AI defense technology unit, by issuing 1.3 million shares (19.87% of its outstanding stock) and a $1.25 million promissory note to Water IO Ltd., a subsidiary of T3 Defense Inc.


Key Events

  • Strategic Acquisition

    BiomX Inc. acquired 100% of Zorronet, an AI defense technology unit, from Water IO Ltd., a subsidiary of T3 Defense Inc.

  • Significant Dilution

    BiomX issued 1,300,000 shares of its common stock, representing 19.87% of its outstanding shares, as part of the acquisition consideration.

  • Financial Obligations Assumed

    BiomX also issued a $1.25 million non-convertible promissory note and assumed earnout payment obligations to Zorronet's founder beneficiaries.

  • New Major Shareholder

    Water IO Ltd., along with its parent T3 Defense Inc. and controlling shareholder Menachem Shalom, now beneficially owns 19.87% of BiomX Inc.


Analysis

This Schedule 13D filing details BiomX Inc.'s acquisition of Zorronet, an AI defense technology unit, from Water IO Ltd., a subsidiary of T3 Defense Inc. While the strategic acquisition of a new technology unit could be beneficial, the terms involve significant dilution for existing BiomX shareholders, as 19.87% of the company's outstanding shares were issued as part of the consideration. Additionally, BiomX Inc. issued a $1.25 million non-convertible promissory note and assumed earnout obligations to Zorronet's founders, adding to its financial liabilities. The agreement also includes a provision for BiomX to file an S-3 registration statement, which could lead to future share sales by the new major shareholder, creating potential stock overhang. The option for Water IO to reverse the deal under certain conditions introduces further risk. Investors should monitor the integration of Zorronet and the impact of the new ownership structure.

At the time of this filing, DFNS was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.5M. The 52-week trading range was $0.42 to $26.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DFNS - Latest Insights

DFNS
Jun 11, 2026, 12:55 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.2573
Real-time Price: $0.2219 info
Change: -$0.0354 (-14%) info
Market Cap: $14.043M info
DFNS
Jun 04, 2026, 5:30 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.360
Real-time Price: $0.2219 info
Change: -$0.1381 (-38%) info
Market Cap: $14.043M info
DFNS
Jun 01, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4856
Real-time Price: $0.2219 info
Change: -$0.2637 (-54%) info
Market Cap: $14.043M info
DFNS
May 29, 2026, 5:54 PM EDT
Filing Type: DEFR14A
Importance Score:
9
Price at Filing: $0.455
Real-time Price: $0.2219 info
Change: -$0.2331 (-51%) info
Market Cap: $14.043M info
DFNS
May 27, 2026, 6:07 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.3424
Real-time Price: $0.2219 info
Change: -$0.1205 (-35%) info
Market Cap: $14.043M info
DFNS
May 26, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.369
Real-time Price: $0.2219 info
Change: -$0.1471 (-40%) info
Market Cap: $14.043M info
DFNS
May 20, 2026, 5:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.3724
Real-time Price: $0.2219 info
Change: -$0.1505 (-40%) info
Market Cap: $14.043M info
DFNS
May 08, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4778
Real-time Price: $0.2219 info
Change: -$0.2559 (-54%) info
Market Cap: $14.043M info
DFNS
Apr 28, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.474
Real-time Price: $0.2219 info
Change: -$0.2521 (-53%) info
Market Cap: $14.043M info
DFNS
Apr 28, 2026, 8:15 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.4701
Real-time Price: $0.2219 info
Change: -$0.2482 (-53%) info
Market Cap: $14.043M info